Q3 2019 Y-mAbs Therapeutics, Inc Earnings Call Transcript
Good day, and welcome to the Y-mAbs Therapeutics, Inc. 2019 Third Quarter Earnings Conference Call. Today's conference is being recorded. Let me quickly remind you that the following discussion contains certain statements that are considered forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Because forward-looking statements involve risks and uncertainties, they are not guarantees of future performance, and actual results may differ materially from those expressed or implied by these forward-looking statements due to a variety of factors, including those risk factors discussed in the company's prospectus supplement dated October 29, 2019, and filed with the SEC on October 31, 2019, and the company's annual report on Form 10-K for the fiscal year ended December 31, 2018, as filed with the SEC on March 22, 2019.
At this time, I'd like to turn the conference over to Thomas Gad, the company's Founder, Chairman and President. Please go ahead, sir.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |